Endothelial cell death may be unfavorable for the structure of plaque because endothelial injury or death will promote lesional thrombosis [12, 13]
This type of fibre is particularly beneficial for GLP-1 users because it: Slows glucose absorption, helping to maintain stable blood sugar levels Promotes feelings of fullness, which works synergistically with the appetite-suppressing effects of GLP-1 medications Supports healthy cholesterol levels by binding to bile acids Feeds beneficial gut bacteria, promoting a healthy microbiome Excellent sources of soluble fibre include oats, barley, psyllium husk, chia seeds, flaxseeds, beans, lentils, apples, and citrus fruits
This lack of transparency hinders consumers ability to make informed decisions about the treatment
GLP-1 Timeline: From Diabetes to Pediatric Weight Management 2005: First GLP-1 medications approved for Type 2 diabetes in adults 2014: FDA approves Saxenda (liraglutide) as the first GLP-1 for weight loss 2022: Wegovy approved for adolescents 12 and older 2023: American Academy of Pediatrics endorses GLP-1s for pediatric obesity 2025: FDA considering approval for children as young as 6 years old Though the FDA approved Saxenda as the first GLP-1 for weight loss back in 2014, it wasnt until the last few years that the popularity and availability of these medications for obesity have skyrocketed
Todays consumers are looking for multifunctional products that simplify their routines and deliver meaningful results, said Kevin Cureton, president and CEO of Solsence
This brain-neurotransmitter mechanism differs from semaglutides GLP-1 action
